Cancer remains the second leading cause of death in the United States. Despite a drop of nearly 3% in the cancer death rate in the United States between 1881 and 1995 (NCI Cancer Facts: www.nci.nih.gov), more than 1.2 million cancers are expected to be diagnosed in 2000, and nearly 552,000 Americans are expected to die of this disease in 2000 (http://www3.cancer.org/cancerinfo/acs_frame.asp?frame=statmenu.html ). African Americans are more likely to develop cancer than whites. Between 1990 and 1994, cancer incidence rates increased 1.2% per year in African Americans whereas they decreased 0.8% per year in whites. Overall cancer mortality rates for both whites and African Americans have declined in recent years, but although the rate of decrease for African Americans has been approximately twice that for whites, African Americans are still at least 50% more likely to die of cancers of the oral cavity, esophagus , stomach, cervix, prostate, uterus, uterus, liver, and pancreas than whites (American Cancer Society Facts and Figures: http://www3.cancer.org/cancerinfo/acs_frame.asp?frame=statmenu.html) . Despite modest gains in the diagnosis and treatment of several cancers, the identification and control of all relevant risk factors as well as a cure, remain elusive goals. While African Americans are over-represented in cancer incidence and mortality, they are seriously under-represented in cancer research. Innovative methods are needed to recruit African Americans into cancer research. Despite the presence of a diverse Howard University Cancer Center faculty with expertise in several cancer-related disciplines, there is not a single course in the entire curriculum of Howard University that is dedicated to cancer. The need for such a course is manifest. Graduate students and faculty in the biomedical sciences, post-doctoral fellows, genetic counselors, and other health professionals do not have access (at Howard) to an integrated oncology course that explores the disparate but related fields of cancer investigation: epidemiology, cellular and molecular biology, nutrition, therapy, behavior, and environmental toxicology. The current partnership grant between Howard University and Johns Hopkins University provides a unique and unprecedented opportunity to combine the resources of both institutions to establish an interdisciplinary, team-taught course in integrative oncology to accomplish the following objectives: 1. Provide graduate level training in cancer biology for academic credit. 2. Make the expertise of research personnel available to graduate students. 3. Help create an academic environment that would enhance the HUCC's prospects in applying for training grants. 4. Increase awareness of opportunities in cancer research. 5. Increase the number of African Americans in cancer research. 6. Increase accessibility to research findings on cancer prevention and cure 7. Increase the general understanding of the incidence and causes of cancer as well as the mechanisms of carcinogenesis. A Graduate Oncology Course Committee has already been set up to develop the syllabus and selective appropriate instructors for each unit of the course.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA091431-02
Application #
6600005
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-06-14
Project End
2003-04-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Howard University
Department
Type
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Khan, Farhan; Ricks-Santi, Luisel J; Zafar, Rabia et al. (2018) Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women. Ann Diagn Pathol 34:170-174
Khan, Farhan; Esnakula, Ashwini; Ricks-Santi, Luisel J et al. (2018) Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women. Pathol Res Pract 214:673-678
Ricks-Santi, Luisel; McDonald, J Tyson; Gold, Bert et al. (2017) Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women. Ethn Dis 27:169-178
Nesoff, Elizabeth D; Milam, Adam J; Bone, Lee R et al. (2017) Tobacco policies and on-premise smoking in bars and clubs that cater to young African Americans following the Maryland Clean Indoor Air Act of 2007. J Ethn Subst Abuse 16:328-343
Weber, Kari A; Heaphy, Christopher M; Rohrmann, Sabine et al. (2016) Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer? Prostate Cancer 2016:3691650
Ricks-Santi, Luisel J; Thompson, Nicole; Ewing, Altovise et al. (2016) Predictors of Self-Reported Family Health History of Breast Cancer. J Immigr Minor Health 18:1175-82
Bamji, Zebalda D; Washington, Kareem N; Akinboye, Emmanuel et al. (2015) Apoptotic Effects of Novel Dithiocarbamate Analogs of Emetine in Prostate Cancer Cell Lines. Anticancer Res 35:4723-32
Ewing, Altovise; Thompson, Nicole; Ricks-Santi, Luisel (2015) Strategies for enrollment of African Americans into cancer genetic studies. J Cancer Educ 30:108-15
Akinboye, Emmanuel S; Bamji, Zebalda D; Kwabi-Addo, Bernard et al. (2015) Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines. Bioorg Med Chem 23:5839-45
Kanaan, Yasmine M; Sampey, Brante P; Beyene, Desta et al. (2014) Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease. Cancer Genomics Proteomics 11:279-94

Showing the most recent 10 out of 69 publications